Summit Therapeutics (SMMT) Operating Leases (2019 - 2026)
Summit Therapeutics' Operating Leases was $16.13 million in Q3 2026, up 495.8% from $2.71 million a year earlier but down 4.2% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Summit Therapeutics came in at $17.5 million, up 406.9% from FY2024.
- Operating Leases has now increased for four consecutive years, with a five-year compound annual growth rate of 197.6% (FY2020 to FY2025).
- In earlier years, Operating Leases was $3.45 million in FY2024 (+5.0%), $3.29 million in FY2023 (+19.1%), $2.76 million in FY2022 (+63.4%) and $1.69 million in FY2021.
- Quarterly Operating Leases has moved between $1.32 million (Q2 2022) and $17.5 million (Q4 2025) over five years.
- Compared with a year earlier, Operating Leases has increased for four straight quarters, with growth averaging 230.2% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q2 2026 (growth of 591.3%); the worst was Q2 2025 (a decline of 51.5%).
- Per Business Quant data, SMMT's Operating Leases in the three quarters before Q3 2026 was $16.83 million (Q2 2026), $16.86 million (Q1 2026) and $17.5 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Summit Therapeutics | 14.26 Bn | 11.63 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.13 Mn |
| Jun 30, 2026 | 16.83 Mn |
| Mar 31, 2026 | 16.86 Mn |
| Dec 31, 2025 | 17.50 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Mar 31, 2025 | 2.91 Mn |
| Dec 31, 2024 | 3.45 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | 5.02 Mn |
| Mar 31, 2024 | 5.82 Mn |
| Dec 31, 2023 | 3.29 Mn |
| Sep 30, 2023 | 3.88 Mn |
| Jun 30, 2023 | 4.33 Mn |
| Mar 31, 2023 | 2.49 Mn |
| Dec 31, 2022 | 2.76 Mn |
| Sep 30, 2022 | 2.97 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.54 Mn |
| Dec 31, 2021 | 1.69 Mn |
API Access
Summit Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();